Invacare Corporation
IVC · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $742 | $872 | $851 | $928 |
| % Growth | -15% | 2.6% | -8.3% | – |
| Cost of Goods Sold | $566 | $633 | $605 | $666 |
| Gross Profit | $175 | $239 | $245 | $262 |
| % Margin | 23.6% | 27.4% | 28.8% | 28.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $260 |
| SG&A Expenses | $227 | $232 | $236 | $260 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $227 | $232 | $236 | $260 |
| Operating Income | -$69 | -$15 | $11 | -$10 |
| % Margin | -9.4% | -1.7% | 1.3% | -1.1% |
| Other Income/Exp. Net | -$18 | -$15 | -$36 | -$46 |
| Pre-Tax Income | -$98 | -$39 | -$24 | -$44 |
| Tax Expense | $3 | $6 | $4 | $9 |
| Net Income | -$101 | -$46 | -$28 | -$53 |
| % Margin | -13.6% | -5.2% | -3.3% | -5.7% |
| EPS | -2.77 | -1.29 | -0.82 | -1.59 |
| % Growth | -114.7% | -57.3% | 48.4% | – |
| EPS Diluted | -2.77 | -1.29 | -0.82 | -1.59 |
| Weighted Avg Shares Out | 37 | 35 | 34 | 34 |
| Weighted Avg Shares Out Dil | 37 | 35 | 34 | 34 |
| Supplemental Information | – | – | – | – |
| Interest Income | -$0 | -$0 | $0 | $0 |
| Interest Expense | $29 | $24 | $28 | $29 |
| Depreciation & Amortization | -$11 | $17 | $21 | $24 |
| EBITDA | -$80 | $2 | $25 | $2 |
| % Margin | -10.8% | 0.2% | 3% | 0.2% |